![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Automation for high and low-volume offerings
By
With the advancement of biologics and protein drugs driving rapid growth for the auto-injector industry, SHL Group’s in-house automation capabilities enable the company to meet the shifting market demands in terms of quantity and quality.
![](https://www.worldpharmaceuticals.net/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)